Annis Gardner Whiting Capital Advisors’s ResMed RMD Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.9K	Sell	102 -19	-16%	-$4.74K	﹤0.01%	702
2025 Q4	$29.1K	Buy	121 +2	+2%	+$511	0.01%	597
2025 Q3	$32.6K	Buy	119 +2	+2%	+$546	0.01%	548
2025 Q2	$30.2K	Buy	117 +34	+41%	+$8.11K	0.01%	491
2025 Q1	$18.6K	Buy	83 +7	+9%	+$1.63K	0.01%	471
2024 Q4	$17.4K	Hold	76	–	–	﹤0.01%	461
2024 Q3	$18.6K	Sell	76 -3	-4%	-$670	0.01%	468
2024 Q2	$15.1K	Buy	79 +3	+4%	+$609	﹤0.01%	621
2024 Q1	$15.1K	Buy	76 +3	+4%	+$550	0.01%	612
2023 Q4	$12.6K	Hold	73	–	–	0.01%	455
2023 Q3	$10.8K	Buy	+73	New	+$13.2K	0.01%	454

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's RMD Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its ResMed (RMD) stake by 16% in Q1 2026, selling an estimated $4.74K and leaving 102 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Annis Gardner Whiting Capital Advisors first reported a position in RMD in Q3 2023 and has held it in 11 quarters since. The position peaked at $32.6K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Annis Gardner Whiting Capital Advisors held 102 shares of ResMed worth $22.9K as of Q1 2026.
Annis Gardner Whiting Capital Advisors sold 19 ResMed shares in Q1 2026, an estimated $4.74K.
ResMed made up ﹤0.01% of Annis Gardner Whiting Capital Advisors's portfolio in Q1 2026, its #702 holding.
Annis Gardner Whiting Capital Advisors first reported a position in ResMed in Q3 2023 and has held it in 11 quarters since.
Annis Gardner Whiting Capital Advisors's ResMed position peaked at $32.6K in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.